Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Highlights

Selected Articles from This Issue

DOI:  Published August 2020
  • Article
  • Info & Metrics
  • PDF
Loading

Challenges and Approaches to Measuring Repeat FIT for Colorectal Cancer Screening

Murphy et al. Page 1557

Effectiveness of fecal immunochemical test (FIT) for colorectal cancer screening may be compromised when patients do not adhere to a regular schedule, while having no standard measure of repeat FIT presents challenges for assessing effectiveness across patient populations and health systems. To address these challenges, Murphy and colleagues compared three measures of repeat FIT in a large population of screen-eligible patients. Estimates of repeat FIT varied widely by the measure used. For example, using a prior screeners measure, 16% of patients completed repeat FIT, whereas 53% of patients completed repeat FIT using proportion of time covered measures. An important next step is to examine the association of these measures with clinical outcomes, such as stage of diagnosis and mortality.

Leveraging GWAS and PheWAS in Childhood Leukemia

Semmes et al. Page 1606

Semmes and colleagues developed a novel methodology for incorporating phenome-wide association study (PheWAS) data into genetic association studies. They applied their methodology to childhood leukemia, identifying novel pleiotropic loci contributing to both acute lymphoblastic leukemia risk and variation in platelet count. Risk loci near IRF1, BAK1, and ERG were successfully replicated in a large childhood leukemia dataset from UK collaborators. The authors demonstrated that PheWAS data can help investigators leverage pleiotrop. to enhance genetic association studies of cancer, potentially identifying the causal risk alleles underlying association signals.

Hematologic Markers and Prostate Cancer Risk: A Prospective Analysis in UK Biobank

Watts et al. Page 1615

Risk factors for prostate cancer are not well understood. Hematologic measures may be used as markers of exposures that could affect prostate cancer risk. Watts and colleagues investigated the associations of hematologic measures with subsequent prostate cancer risk in 210,000 men. Men with higher red blood cell and platelet counts and lower measures of red blood cell volume had a higher risk of prostate cancer diagnosis. Men with higher white blood cell and neutrophil counts had a higher risk of prostate cancer mortality. These results may support the role of factors including testosterone and inflammation/infection in prostate cancer development and progression.

Cumulative Burden of Chronic Health Conditions in Adult Survivors of Childhood Bone Sarcomas

Bishop et al. Page 1627

Adult survivors of bone sarcomas experience risk of chronic health conditions. Bishop and colleagues comprehensively characterized the cumulative burden of chronic health conditions in survivors of childhood osteosarcoma and Ewing sarcoma, as well as physical and neurocognitive performance, compared to community controls. The authors found that by age 35 years, a survivor was expected to accumulate, on average, 10 or more chronic health conditions, including more than three severe or life-threatening conditions. Survivors demonstrated significantly impaired physical function. Survivors with multiple grade 3–4 conditions had increased risk of executive function. Preemptive action to reduce the cumulative burden of late effects may allow for prolonged survival and improved quality of life.

  • ©2020 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 29 (8)
August 2020
Volume 29, Issue 8
  • Table of Contents
  • Table of Contents (PDF)
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Selected Articles from This Issue
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Selected Articles from This Issue
Cancer Epidemiol Biomarkers Prev August 1 2020 (29) (8) 1513;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Selected Articles from This Issue
Cancer Epidemiol Biomarkers Prev August 1 2020 (29) (8) 1513;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Challenges and Approaches to Measuring Repeat FIT for Colorectal Cancer Screening
    • Leveraging GWAS and PheWAS in Childhood Leukemia
    • Hematologic Markers and Prostate Cancer Risk: A Prospective Analysis in UK Biobank
    • Cumulative Burden of Chronic Health Conditions in Adult Survivors of Childhood Bone Sarcomas
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Selected Articles from This Issue
  • Selected Articles from This Issue
  • Selected Articles from This Issue
Show more Highlights
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement